Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11324749 Combination therapy for treatment of hematological diseases

Patent 11324749 was granted and assigned to Incyte on May, 2022 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 29 May, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 29 May, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11992490 Use of JAK1 inhibitors for the treatment of cutaneous lupus erythematosus and Lichen planus (LP)
0
Edits on 27 Dec, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 27 Dec, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11851442 Tricyclic fused thiophene derivatives as JAK inhibitors
0
Edits on 16 Oct, 2023
"Add patent inventor(s)"
Golden AI profile picture
Golden AI
edited on 16 Oct, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Inventor Names
Albert Assad0
Edits on 26 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 26 Apr, 2023
Edits on 24 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 24 Apr, 2023
Edits on 25 Mar, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 25 Mar, 2023
Edits on 23 Feb, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 23 Feb, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11584961 Biomarkers for inflammatory skin disease
0
Edits on 26 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 26 Sep, 2022
Edits on 23 Sep, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 23 Sep, 2022
Infobox
Is a
Patent
Patent
0
Patent Applicant
Incyte
Incyte
0
Current Assignee
Incyte
Incyte
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
113247490
Date of Patent
May 10, 2022
0
Patent Application Number
166702890
Date Filed
October 31, 2019
0
Patent Citations
‌
US Patent 10166191 Sustained-release dosage forms of ruxolitinib
0
‌
US Patent 10596161 Low dose combination therapy for treatment of myeloproliferative neoplasms
0
‌
US Patent 10899736 Processes and intermediates for making a JAK inhibitor
0
Patent Primary Examiner
‌
Samantha L Shterengarts
0
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 23 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 23 Sep, 2022
Edits on 19 May, 2022
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 19 May, 2022
Edits made to:
Infobox (+12 properties)
Article (+393 characters)
‌

 US Patent 11324749 Combination therapy for treatment of hematological diseases

Article

The present application relates to treatment of a hematological disease selected from leukemia, lymphoma, and multiple myeloma in a patient in need thereof, comprising administering to the patient: (a) a therapeutically effective amount of a selective JAK1 inhibitor; (b) a therapeutically effective amount of an immunomodulatory agent, and (c) a therapeutically effective amount of a steroid.

Infobox
Is a
Patent
Patent
Patent applicant
Incyte
Incyte
Current assignee
Incyte
Incyte
Patent jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent number
11324749
Date of patent
May 10, 2022
Patent application number
16670289
Date Filed
October 31, 2019
Patent citations
‌
US Patent 10166191 Sustained-release dosage forms of ruxolitinib
‌
US Patent 10596161 Low dose combination therapy for treatment of myeloproliferative neoplasms
‌
US Patent 10899736 Processes and intermediates for making a JAK inhibitor
Patent primary examiner
‌
Samantha L Shterengarts

Find more entities like US Patent 11324749 Combination therapy for treatment of hematological diseases

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.